Chen L et al: Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI. J Neurosci Res. 97(4):467-79., 2018
Liu Y et al: Progress in the diagnosis and management of chorea-acanthocytosis. Chin Med Sci J. 33(1):53-9, 2018
Sobue G et al: Pathogenesis of frontotemporal lobar degeneration: insights from loss of function theory and early involvement of the caudate nucleus. Front Neurosci. 12:473, 2018
Goveas J et al: Diffusion-MRI in neurodegenerative disorders. Magn Reson Imaging. 33(7):853-76, 2015
Mason S et al: Progress in Huntington's disease: the search for markers of disease onset and progression. J Neurol. 262(8):1990-5, 2015
Stroedicke M et al: Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity. Genome Res. 25(5):701-13, 2015
Valor LM: Epigenetic-based therapies in the preclinical and clinical treatment of Huntington's disease. Int J Biochem Cell Biol. Oct;67:45-8, 2015
Wassef SN et al: T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression. Mov Disord. ePub, 2015
Ahmad R et al: PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology. 82(3):279-81, 2014
Cole JH et al: Test-retest reliability of diffusion tensor imaging in Huntington's disease. PLoS Curr. 6, 2014
Georgiou-Karistianis N et al: Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study. Hum Brain Mapp. 35(5):1847-64, 2014
Hensman Moss DJ et al: C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 82(4):292-9, 2014
Macerollo A et al: Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty. Eur J Neurol. 21(2):e16-7, 2014
Matsui JT et al: Diffusion weighted imaging of prefrontal cortex in prodromal huntington's disease. Hum Brain Mapp. 35(4):1562-73, 2014
Novak MJ et al: White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex. 52:98-112, 2014
Phillips O et al: The corticospinal tract in Huntington's disease. Cereb Cortex. 25(9):2670-82, 2014
Adam OR et al: Symptomatic treatment of Huntington disease. Neurotherapeutics. 5(2):181-97, 2008
Imarisio S et al: Huntington's disease: from pathology and genetics to potential therapies. Biochem J. 412(2):191-209, 2008
Alberch J et al: Neurotrophic factors in Huntington's disease. Prog Brain Res. 146:195-229, 2004
Schapiro M et al: MR imaging and spectroscopy in juvenile Huntington disease. Pediatr Radiol. 34(8):640-3, 2004
Becker G et al: Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord. 16(1):23-32, 2001
Chen L et al: Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI. J Neurosci Res. 97(4):467-79., 2018
Liu Y et al: Progress in the diagnosis and management of chorea-acanthocytosis. Chin Med Sci J. 33(1):53-9, 2018
Sobue G et al: Pathogenesis of frontotemporal lobar degeneration: insights from loss of function theory and early involvement of the caudate nucleus. Front Neurosci. 12:473, 2018
Goveas J et al: Diffusion-MRI in neurodegenerative disorders. Magn Reson Imaging. 33(7):853-76, 2015
Mason S et al: Progress in Huntington's disease: the search for markers of disease onset and progression. J Neurol. 262(8):1990-5, 2015
Stroedicke M et al: Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity. Genome Res. 25(5):701-13, 2015
Valor LM: Epigenetic-based therapies in the preclinical and clinical treatment of Huntington's disease. Int J Biochem Cell Biol. Oct;67:45-8, 2015
Wassef SN et al: T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression. Mov Disord. ePub, 2015
Ahmad R et al: PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology. 82(3):279-81, 2014
Cole JH et al: Test-retest reliability of diffusion tensor imaging in Huntington's disease. PLoS Curr. 6, 2014
Georgiou-Karistianis N et al: Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study. Hum Brain Mapp. 35(5):1847-64, 2014
Hensman Moss DJ et al: C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 82(4):292-9, 2014
Macerollo A et al: Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty. Eur J Neurol. 21(2):e16-7, 2014
Matsui JT et al: Diffusion weighted imaging of prefrontal cortex in prodromal huntington's disease. Hum Brain Mapp. 35(4):1562-73, 2014
Novak MJ et al: White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex. 52:98-112, 2014
Phillips O et al: The corticospinal tract in Huntington's disease. Cereb Cortex. 25(9):2670-82, 2014
Adam OR et al: Symptomatic treatment of Huntington disease. Neurotherapeutics. 5(2):181-97, 2008
Imarisio S et al: Huntington's disease: from pathology and genetics to potential therapies. Biochem J. 412(2):191-209, 2008
Alberch J et al: Neurotrophic factors in Huntington's disease. Prog Brain Res. 146:195-229, 2004
Schapiro M et al: MR imaging and spectroscopy in juvenile Huntington disease. Pediatr Radiol. 34(8):640-3, 2004
Becker G et al: Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord. 16(1):23-32, 2001
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.